Fifteen-minute consultation: autoimmune encephalitis

Sarah Clews1, Sharmila Jeyasing1, Ming Lim1

  • 1Children's Neurosciences, Evelina London Children's Hospital, Guys and St Thomas' NHS Foundation Trust, King's Health Partners Academic Health Sciences Centre, London, UK.

Insights

Autoimmune encephalitis (AE) is a serious condition increasingly diagnosed in children, potentially causing long-term disability. This case study details its key features, diagnosis, and management, differentiating between autoantibody subtypes.

Area of Science:

  • Pediatric Neurology
  • Neuroimmunology
  • Autoimmune Disorders

Background:

  • Autoimmune encephalitis (AE) is a group of immune-mediated disorders affecting the central nervous system.
  • AE is increasingly diagnosed in pediatric populations, posing a significant risk for severe, long-term neurological sequelae.
  • Early recognition and management are crucial for improving patient outcomes.

Purpose of the Study:

  • To present a clinical case illustrating the diagnosis and management of autoimmune encephalitis in a child.
  • To describe common neurological presentations of AE in pediatric patients.
  • To highlight the distinctions between various autoantibody subtypes associated with AE.

Main Methods:

  • Retrospective review of a pediatric clinical case with confirmed autoimmune encephalitis.
  • Analysis of clinical presentation, neuroimaging, cerebrospinal fluid analysis, and autoantibody testing.
  • Correlation of clinical syndromes with specific autoantibody profiles.

Main Results:

  • The case demonstrated characteristic neurological symptoms and diagnostic findings consistent with AE.
  • Different autoantibody subtypes were associated with distinct neurological syndromes and disease trajectories.
  • Timely immunotherapy led to clinical improvement, underscoring the treatable nature of AE.

Conclusions:

  • Autoimmune encephalitis is a critical, treatable neurological condition in children that requires prompt diagnosis and intervention.
  • Understanding the specific autoantibody subtype is essential for tailoring treatment and predicting prognosis.
  • Clinical case studies are valuable for illustrating the multifaceted approach to managing pediatric AE.